This Statement on Schedule 13D (this “Schedule 13D”) relates to the common stock, $.40 par value (the “Common Stock”), of Aerosonic Corporation, a Florida corporation (the “Issuer”), having its principal executive offices at 1212 North Hercules Avenue, Clearwater, Florida 33765.

This Schedule 13D is being filed by Electro Technik Industries, Inc., a Florida corporation (“ETI” or the “Reporting Person”).  The address of the principal business office of ETI is 12449 Enterprise Boulevard, Largo, Florida 33773.

The principal business of ETI is the development and manufacturing of microwave, resistors and magnetic products for commercial and military markets.

The name, present principle occupation or employment, present business address and country of citizenship of each director and executive officer of ETI is set forth on Schedule I attached hereto.

During the past five years, neither ETI nor, to the best of ETI’s knowledge, any director or executive officer of ETI, has been (i) convicted of in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

An aggregate of 486,000 shares of Common Stock reported in this Schedule 13D as being beneficially owned by ETI were acquired in open market purchases.  The aggregate purchase price for the shares of Common Stock purchased by ETI in open market purchases was $201,235.72.  The source of funding for the purchases of such shares was the general working capital of ETI. See Item 5(c) for additional details.

ETI acquired the shares of Common Stock for investment purposes. ETI intends to assess its investments in the Issuer from time to time on the basis of various factors, including, without limitation, the Issuer’s business, financial condition, results of operations and prospects, general economic, market and industry conditions, including the market price of the Common Stock, as well as other developments and other investment opportunities. Depending upon the foregoing factors or any other factors deemed relevant by ETI, it or its affiliates may acquire additional shares of Common Stock in open market transactions, privately negotiated transactions or otherwise. ETI may also determine to dispose of all or part of the shares of Common Stock in open market transactions, privately negotiated transactions or otherwise. Although ETI’s current purchase of the Issuer’s Common Stock has been made for investment, ETI’s ongoing assessment of the Issuer’s operating performance, strategic directions or other matters, could result in or related to, among other things, any of the matters set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as described herein, ETI does not have any present plans or proposals that would result in, or relate to, any of the matters set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

(a), (b)  According to the Issuer’s Quarterly Report on Form 10-Q for the Quarter Ended October 31, 2008, there were 3,598,552 shares of Common Stock outstanding as of October 31, 2008.  Based on such information and including the transactions described in Item 5(c) below, ETI reports beneficial ownership of 486,000 shares of Common Stock, which represents approximately 13.5% of the total number of issued and outstanding shares of Common Stock.  Voting and dispositive power with respect to such shares of Common Stock is held solely by ETI.

3